The management of secondary immune deficiencies, including HIV/AIDS
With 25 years of experience, the McGill University Health Centre (MUHC) Allergy and Immunology Division has pioneered the management of secondary immune deficiencies, including HIV/AIDS, the most significant acquired immune deficiency in history. The Division provides world class care and treatment, professional training and instruction, and conducts advanced research. It also pioneered a unique “patient focused interdisciplinary care” model and has both a dynamic research agenda and a broad teaching program.
Our centre’s HIV/AIDS activities have a distinct immune focus. It is thus in a position to establish the much needed care models in accelerated ageing, and to continue our cutting edge immunologic and metabolic clinical research in this area.
Our dynamic Allergy service offers traditional diagnostic activities and an extensive and innovative invasive allergy program.
In Autoimmunity, we have the largest Lupus Registry in Quebec (the second largest in Canada) with a distinguished record in clinical research.
Immune Deficiency Treatment Centre
The MUHC Immune Deficiency Treatment Centre (IDTC), is the only dedicated diagnostic and treatment centre in Canada for adults with inherited and acquired immune defects. It is also the only program with a formal transition from pediatric to adult care, for children with primary immune deficiency.
The Division of Adult Allergy & Clinical Immunology continues to be a leader in Quebec, and Canada, by providing premier clinical activities in:
- Invasive Allergy
- Adult Immune Deficiency
- Translational and Interventional Immunology.
The division is one of two Canadian Centres of Excellence to be recognized by the Federation of Clinical Immunology Societies (FOCIS).